CURRENT PUBLICATIONS
Effectors and Memories: Bcl-6 and Blimp-1 in T and B Lymphocyte Differentiation The new findings unexpectedly point to the Bcl-6 and Blimp-1 regulatory axis as a ubiquitous mechanism for controlling effector and memory lymphocyte differentiation and function. [Nat Immunol] Membrane-Associated Hsp72 from Tumor-Derived Exosomes Mediates STAT3-Dependent Immunosuppressive Function of Mouse and Human Myeloid-Derived Suppressor Cells Here, researchers have isolated tumor-derived exosomes (TDEs) from mouse cell lines and shown that an interaction between TDE-associated Hsp72 and myeloid-derived suppressor cells (MDSCs) determines the suppressive activity of the MDSCs via activation of Stat3. [J Clin Invest] The Architectural Pattern of FOXP3-Positive T Cells in Follicular Lymphoma is an Independent Predictor of Survival and Histologic Transformation Researchers conclude that FOXP3+ cell distribution significantly predicts survival and risk of transformation in follicular lymphoma. [Blood] Tolerogenic Dendritic Cells Generated with Different Immunosuppressive Cytokines Induce Antigen-Specific Anergy and Regulatory Properties in Memory CD4+ T Cells In this study, researchers generated human monocyte-derived dendritic cells (DCs) by culture with GM-CSF and IL-4 (control DCs), as well as tolerogenic DCs (tDCs) by adding IL-10, IL-10/TGF-(beta)1, or IL-10/IL-6. [J Immunol] Myelin Basic Protein Priming Reduces the Expression of FOXP3 in T Cells Via Nitric Oxide The present study was undertaken to investigate the crosstalk between nitric oxide and regulatory T cells. [J Immunol] Dendritic Cells Support Homeostatic Expansion of FOXP3+ Regulatory T Cells in Foxp3.LuciDTR Mice For the investigation of regulatory T cell (Treg) homeostatic expansion, researchers introduced in this study novel BAC transgenic mice, designated Foxp3.LuciDTR, coexpressing enhanced GFP, luciferase for bioluminescence imaging of Tregs, and the diphtheria toxin receptor for specific ablation of Tregs. [J Immunol] Ex Vivo Monitoring of Human Cytomegalovirus-Specific CD8+ T Cell Responses Using the QuantiFERON(R)-CMV Assay in Allogeneic Hematopoietic Stem Cell Transplant Recipients Attending an Irish Hospital The QuantiFERON®-CMV assay for cellular human cytomegalovirus-specific immunity was evaluated in allogeneic hematopoietic stem cell transplant recipients recipients (n = 43) and patients with hematological malignancies (n = 29) attending a tertiary-care Irish hospital. [J Med Virol]
|